Published in Clin J Am Soc Nephrol on December 17, 2009
Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. Am J Kidney Dis (2013) 0.98
Nephrologists' perspectives on dialysis treatment: results of an international survey. BMC Nephrol (2014) 0.91
Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol (2013) 0.90
Estimation of quality of life in haemodialysis patients. Indian J Pharm Sci (2012) 0.85
A Thematic Synthesis of the Experiences of Adults Living with Hemodialysis. Clin J Am Soc Nephrol (2016) 0.83
The association of mental health over time with cardiac outcomes in HEMO study patients. Clin J Am Soc Nephrol (2012) 0.79
Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease. BMC Nephrol (2014) 0.76
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. BMJ Open (2016) 0.75
Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis. Int J Nephrol Renovasc Dis (2016) 0.75
Emotion-oriented coping increases the risk of depression among caregivers of end-stage renal disease patients undergoing hemodialysis. Int Urol Nephrol (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care (1992) 4.58
Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis (1997) 2.82
Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. J Am Soc Nephrol (2006) 2.38
Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Kidney Int (2001) 2.34
Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis (2003) 2.18
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care (2000) 1.84
The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care (1998) 1.76
Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2003) 1.72
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int (2004) 1.71
Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol (2008) 1.44
Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 1.42
Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant (2001) 1.41
Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol (2000) 1.36
Quality of life assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health (2007) 1.27
Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire. Qual Life Res (2000) 1.02
Dialysis dose and frequency. Nephrol Dial Transplant (2004) 1.01
Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol (2007) 1.00
Assessing response bias from missing quality of life data: the Heckman method. Health Qual Life Outcomes (2004) 1.00
Improving the care of ESRD patients: a success story. Health Care Financ Rev (2003) 0.91
Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS. Nephrol Dial Transplant (2008) 0.89
Response bias influences mental health symptom reporting in patients with obstructive sleep apnea. Ann Behav Med (2001) 0.85
Revisiting the hemodialysis dose. Semin Dial (2006) 0.79
Exercise training in peripheral vascular arterial disease in hemodialysis patients: a case report and a review. J Nephrol (2006) 0.78
Should the medicare ESRD program pay for daily dialysis? An ethical analysis. Adv Chronic Kidney Dis (2007) 0.78
Prolonged use of intradialysis parenteral nutrition in elderly malnourished chronic haemodialysis patients. Nephrol Dial Transplant (1998) 0.78
Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA (2005) 9.61
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med (2002) 4.24
Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med (2002) 2.81
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology (2005) 2.02
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int (2004) 1.71
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol (2004) 1.69
Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med (2014) 1.64
A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes (2011) 1.63
Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol (2006) 1.61
The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59
Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis (2002) 1.56
Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis (2007) 1.53
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction. A multicenter, randomized, controlled, clinical effectiveness trial. Ann Intern Med (2002) 1.49
Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2011) 1.47
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant (2004) 1.46
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis (2008) 1.46
Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis (2003) 1.45
External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol (2003) 1.35
Improving the reliability of physician performance assessment: identifying the "physician effect" on quality and creating composite measures. Med Care (2009) 1.29
Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis (2005) 1.29
Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol (2005) 1.28
Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis (2004) 1.27
Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr (2002) 1.26
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology (2004) 1.25
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol (2007) 1.25
Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2010) 1.24
Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol (2006) 1.23
Racial differences in health-related quality of life among hemodialysis patients. Kidney Int (2004) 1.22
Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis (2003) 1.17
Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol (2007) 1.15
Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci (2011) 1.14
Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.13
Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int (2011) 1.13
The empirical basis for determinations of medical futility. J Gen Intern Med (2010) 1.13
Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol (2013) 1.10
Imperial or empirical measures of dialysis quality? Am J Kidney Dis (2007) 1.09
Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med (2007) 1.08
Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2010) 1.05
Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions. Prev Med (2004) 1.05
IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS. Immunol Cell Biol (2006) 1.05
Emergency medical service predictive instrument-aided diagnosis and treatment of acute coronary syndromes and ST-segment elevation myocardial infarction in the IMMEDIATE trial. Prehosp Emerg Care (2011) 1.05
The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc (2008) 1.05
Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol (2005) 1.04
Computerized decision support for EPO dosing in hemodialysis patients. Am J Kidney Dis (2009) 1.04
ESRD Networks: past, present, and challenges for the future. Clin J Am Soc Nephrol (2012) 1.01
Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Am J Cardiol (2007) 1.01
Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol (2012) 1.00
Successful dissemination of a community-based strength training program for older adults by peer and professional leaders: the people exercising program. J Am Geriatr Soc (2008) 0.99
A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol (2007) 0.97
Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care (2007) 0.96
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am J Cardiol (2003) 0.96
Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol (2014) 0.95
Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study. J Am Soc Nephrol (2003) 0.94
Variation in fistula use across dialysis facilities: is it explained by case-mix? Clin J Am Soc Nephrol (2010) 0.93
Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration. Am J Kidney Dis (2013) 0.90
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2008) 0.89
The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization. Am J Kidney Dis (2011) 0.88
The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study. Am J Emerg Med (2004) 0.88
Hematocrit and left ventricular mass: the Framingham Heart study. J Am Coll Cardiol (2004) 0.88
Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction. J Clin Epidemiol (2004) 0.87
Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol (2013) 0.87
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 0.87
Both patient and facility contribute to achieving the Centers for Medicare and Medicaid Services' pay-for-performance target for dialysis adequacy. J Am Soc Nephrol (2011) 0.87
Transvenous cardiac device wires and vascular access in hemodialysis patients. Am J Kidney Dis (2011) 0.86
Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer (2004) 0.86
Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res (2007) 0.86
Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. J Nucl Cardiol (2004) 0.84
Preferences for current health and their association with outcomes in patients with kidney disease. Med Care (2007) 0.82
Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen? Am J Kidney Dis (2005) 0.80
Developing decision support for dialysis treatment of chronic kidney failure. IEEE Trans Inf Technol Biomed (2005) 0.80
Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. Hemodial Int (2010) 0.80
Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci (2010) 0.80